Home Media Library Press Press Releases Press Releases +++ “Caramel Receptor” Found ++++++ 6th Munich Life Science Pitch Day at the IZB with over 20 investors ++++++ Arne Treinies new CFO and Managing Director of AMSilk +++ PDF archive 2018 11. October 2018Gilead Sciences, ChromoTek and Johnson & Johnson Innovation present at the Biotech Press Lounge 20. August 2018Pet therapeutic antibody firm adivo announces closure of seed-financing round 2. August 2018GNA Biosolutions, a Munich based Biotech Company, wins AACC’s Disruptive Technology Award in Chicago 14. June 2018Innovative start-ups present to leading life science investors at the IZB 26. May 2018New ways to invest in cancer drugs 22. March 2018Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer 15. March 2018Origenis Appoints Thomas Loeser as Chief Financial Officer 8. February 2018New Technologies from the IZB are revolutionizing medical diagnostics 5. September 2017Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million 6. July 2017Start-ups profit from being in close contact with the venture capital scene 2017 11. October 2018Gilead Sciences, ChromoTek and Johnson & Johnson Innovation present at the Biotech Press Lounge 20. August 2018Pet therapeutic antibody firm adivo announces closure of seed-financing round 2. August 2018GNA Biosolutions, a Munich based Biotech Company, wins AACC’s Disruptive Technology Award in Chicago 14. June 2018Innovative start-ups present to leading life science investors at the IZB 26. May 2018New ways to invest in cancer drugs 22. March 2018Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer 15. March 2018Origenis Appoints Thomas Loeser as Chief Financial Officer 8. February 2018New Technologies from the IZB are revolutionizing medical diagnostics 5. September 2017Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million 6. July 2017Start-ups profit from being in close contact with the venture capital scene
